Disclosure of Industry Payments to Prescribers: Industry Payments Might be a Factor Impacting Generic Drug Prescribing

摘要

PurposePharmaceutical companies paid at least $3.91 billion to prescribers in 2013, yet evidence indicating whether industry payments shift prescribing away from generics is limited. This study examined the association between amount of industry payments to prescribers and generic drug prescribing rates among Medicare Part D prescribers.